Evaluation of multi skin test in colorectal cancer patients and effects of serum immunosuppressive factor and cytokine production of peripheral mononuclear cells

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 2, 1996, Pages 159-163

  Kondo, Yukifumi ^a,b   Uchino, Junichi ^a   Sawaguchi, Yuji ^a   Shirato, Hiroshi ^a   Gondo, Hiroshi ^a   Hase, Taiji ^a   Saito, Isao ^a   Higashi, Tsuneshi ^a   Hosokawa, Masuo ^a   Kobayashi, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Sapporo Kosei General Hospital   (Japan)

Author keywords

Colorectal cancer; Delayed skin reaction; Immunosuppressive factor; Interleukin 1; Interleukin 2

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; SCORING SYSTEM; SKIN TEST;

ADULT; AGED; ANTIGENS, FUNGAL; ANTIGENS, VIRAL; BIOLOGICAL FACTORS; CANDIDA; COLONIC NEOPLASMS; DISEASE PROGRESSION; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOCOMPETENCE; INTERLEUKIN-1; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MUMPS VIRUS; RECTAL NEOPLASMS; SKIN; SKIN TESTS; STREPTODORNASE AND STREPTOKINASE; TRICHOPHYTON; TUBERCULIN TEST;

EID: 9244242518     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199604000-00014     Document Type: Article

References (23)

1. Smith JL, Cowling DC, Barker CR. Response of lymphocytes in chronic leukemia to plant mitogens. Lancet 1972;2:229-33.
2. Gillette RW, Boone CW. Changes in phytohemagglutinin response due to presence of tumors. J Natl Cancer Inst 1973;50: 1391-3.
3. Field EJ, Caspary EA. Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer 1972;26:164-73.
4. Urushizaki I, Ishitani K, Nagai T, Gocho Y, Koyama R. Immunosuppressive factors in the serum of patients with gastric carcinoma. Gan To Kagaku Ryoho 1977;98:413-21.
5. Lurie BB, Bill DM, Zamcheck N, Steward AM, Helms RA. Diagnosis and prognosis in colon cancer based on a profile of immune reactivity. J Natl Cancer Inst 1975;54:319-25.
6. Pietsch JB, Meakins JL, Maclean LD. The delayed hypersensitivity response: application in clinical surgery. Surgery 1977;82: 349-55.
7. Pihl E, Hughes ESR, Nind APP, Nairm RC. Colonic carcinoma clinicopathological correlation with immunoreactivity. Br Med J 1975;3:742-3.
8. Shafir M, Bekesi JA, Papatestas A, Slater G, Aufses AH. Preoperative and postoperative immunological evaluation of patients with colorectal cancer. Cancer 1980;46:700-5.
9. Hattori T, Nakajima T, Nakazato H, et al. Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer with special reference to the change in stimulation index after gastrectomy. Jpn J Surg 1990;20:127-36.
10. Lurie BB, Bill DM, Zamcheck N, Steward AM, Helms RA. Diagnosis and prognosis in colon cancer based on a profile of immune reactivity. J Natl Cancer Inst 1975;54:319-25.
11. Elhilali MM, Brosman SA, Vescera C, Paul JG, Fahey JL. The effects of treatment on delayed cutaneous hypersensitive response (DNCB, Croton oil recall antigen) in patients with genitourinary cancer. Cancer 1978;41:1765-70.
12. Kaplan MS, Mino FO, Kummerfeld KB, Lundak RL. PHA stimulated immune response assay in colorectal carcinoma patients. Arch Surg 1975;110:1217-20.
13. Bates SE, Suen JY, Tranum BL. Immunological skin testing and interpretation - A plea for uniformity. Cancer 1981;47:1369-76.
14. Morris DL, Hersh EM, Hsi BP, Gutterman JU, Marshall MM, Movligit GM. Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates. Cancer Res 1979;39:219-26.
15. Sohnle PG, Larson SE, Lech CC, Guansing AR. Failure of lymphokine-producing lymphocytes from aged humans to undergo activation by recall antigens. J Immunol 1980;124:2169-74.
16. Hosokawa M, Kobayashi H. Estimation of immune statues of cancer patients by skin reaction test using multiple antigens. Biotherapy 1991;840-2 (in Japanese).
17. Berkowitz RB, Tinkelman DG, Lutz C, Grummie A, Smith K. Evaluation of the multi-test device for immediate hypersensitivity skin testing. J Allergy Clin Immunol 1992;90:979-85.
18. Platt JL, Grant BW, Eddy AA, Michael AF. Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med 1983;158:1227-42.
19. Economou JS, Colouhoun SD, Anderson TM, et al. Interleukin-1 and tumor necrosis factor produced by tumor associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients. Int J Cancer 1988;42:712-14.
20. Garrand O, Faucheer AS, Legrand E. Impairment of monocyte functions in advanced head neck cancer. Immunol Lett 1988;18: 213-8.
21. Moertel CG, Fleming TR, MacDonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:325-58.
22. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Randomized, controlled study on adjuvant immunotherapy with PSK in curative resected colorectal cancer. Dis Colon Rectum 1992;35:123-30.
23. Nakazato H, Sakamoto J, Koike A, Saji S, Ogawa N. A 3-phase randomized controlled trial of Biological Response Modifier to gastric cancer using PSK and 5-FU administration. Biotherapy 1990;4:782-6 (in Japanese).